Medtronic plc (MDT)
NYSE: MDT · Real-Time Price · USD
88.12
-1.99 (-2.21%)
At close: Nov 7, 2024, 4:00 PM
88.50
+0.38 (0.43%)
Pre-market: Nov 8, 2024, 9:21 AM EST
| Period Ending | Jun 30, 2024 | Mar 31, 2024 | Dec 31, 2023 | Sep 30, 2023 | Jun 30, 2023 | Apr 28, 2023 | Jan 27, 2023 | Oct 28, 2022 | Jul 29, 2022 | Apr 29, 2022 | Jan 28, 2022 | Oct 29, 2021 | Jul 30, 2021 | Apr 30, 2021 | Jan 29, 2021 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Cardiovascular Revenue | 12.16B | 12.00B | 11.47B | 11.32B | 11.11B | - | 11.22B | 11.19B | 11.25B | ||||||
| Cardiovascular Revenue Growth | 9.48% | 7.00% | 2.52% | 0.64% | -2.76% | - | -1.33% | -1.24% | 0.14% | ||||||
| Neuroscience Revenue | 9.51B | 9.41B | 9.11B | 8.94B | 8.77B | - | 8.85B | 8.74B | 8.69B | ||||||
| Neuroscience Revenue Growth | 8.41% | 6.32% | 4.19% | 2.84% | -0.17% | - | 0.79% | -0.19% | 0.07% | ||||||
| Medical Surgery Revenue | 8.48B | 8.53B | 8.47B | 8.39B | 8.25B | - | 8.44B | 8.59B | 8.82B | ||||||
| Medical Surgery Revenue Growth | 2.87% | 1.04% | -1.47% | -4.91% | -9.79% | - | -8.76% | -7.33% | -4.72% | ||||||
| Diabetes Revenue | 2.56B | 2.49B | 2.40B | 2.31B | 2.25B | - | 2.26B | 2.28B | 2.31B | ||||||
| Diabetes Revenue Growth | 13.90% | 9.89% | 5.27% | 0.30% | -3.98% | - | -5.19% | -6.41% | -4.79% |
Revenue by Geography
| Period Ending | Jun 30, 2024 | Mar 31, 2024 | Dec 31, 2023 | Sep 30, 2023 | Jun 30, 2023 | Apr 28, 2023 | Jan 27, 2023 | Oct 28, 2022 | Jul 29, 2022 | Apr 29, 2022 | Jan 28, 2022 | Oct 29, 2021 | Jul 30, 2021 | Apr 30, 2021 | Jan 29, 2021 | Oct 30, 2020 | Jul 31, 2020 | Apr 24, 2020 | Jan 24, 2020 | Oct 25, 2019 | Jul 26, 2019 | Apr 26, 2019 | Jan 25, 2019 | Oct 26, 2018 | Jul 27, 2018 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| US Revenue | 16.72B | 16.56B | 16.70B | 16.64B | 16.53B | 16.37B | 15.99B | 15.87B | |||||||||||||||||
| US Revenue Growth | 1.14% | 1.15% | 4.38% | 4.83% | 4.63% | 1.48% | -1.39% | -2.15% | |||||||||||||||||
| Rest of World Revenue | 15.86B | 15.80B | 15.62B | 15.32B | 15.03B | 14.85B | 14.78B | 14.94B | |||||||||||||||||
| Rest of World Revenue Growth | 5.52% | 6.38% | 5.72% | 2.56% | -1.60% | -4.49% | -5.06% | -4.11% |
Operating Expense Breakdown
| Period Ending | Jun 30, 2024 | Mar 31, 2024 | Dec 31, 2023 | Sep 30, 2023 | Jun 30, 2023 |
|---|---|---|---|---|---|
| Selling, General, and Administrative | 10.78B | 10.74B | 10.59B | 10.53B | 10.46B |
| Selling, General, and Administrative Growth | 3.04% | 3.09% | 2.12% | 2.09% | 1.44% |
| Research and Development | 2.74B | 2.74B | 2.70B | 2.69B | 2.67B |
| Research and Development Growth | 2.69% | 1.48% | -0.26% | 0.22% | -0.60% |
| Amortization | 1.68B | 1.69B | 1.70B | 1.71B | 1.70B |
| Amortization Growth | -1.58% | -0.35% | -0.82% | -0.18% | -0.99% |
| Litigation | 190.00M | 149.00M | - | 75.00M | 10.00M |
| Litigation Growth | 1,800.00% | - | - | - | - |
| Restructuring | 219.00M | 226.00M | 408.00M | 426.00M | 416.00M |
| Restructuring Growth | -47.36% | -39.89% | 270.91% | 407.14% | 550.00% |
| Other Expenses | 464.00M | 464.00M | 43.00M | -99.00M | -165.00M |
Source: Business metrics provided by Main Street Data and sourced from official company press releases and documents.